GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
1-Year Return
66.36%
This Quarter Return
+11.03%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$3.29B
AUM Growth
+$16.1M
(+0.49%)
Cap. Flow
-$202M
Cap. Flow
% of AUM
-6.13%
Top 10 Holdings %
Top 10 Hldgs %
27.92%
Holding
180
New
10
Increased
72
Reduced
83
Closed
15
Top Buys
| 1 |
RB Global
RBA
|
$38.3M |
| 2 |
Twilio
TWLO
|
$29.1M |
| 3 |
Phreesia
PHR
|
$25M |
| 4 |
Sprout Social
SPT
|
$19.4M |
| 5 |
Ameresco
AMRC
|
$18M |
Top Sells
| 1 |
CoStar Group
CSGP
|
$39.4M |
| 2 |
Toast
TOST
|
$28.6M |
| 3 |
Enphase Energy
ENPH
|
$24.4M |
| 4 |
Axon Enterprise
AXON
|
$24.3M |
| 5 |
HubSpot
HUBS
|
$19.2M |
Sector Composition
| 1 | Technology | 42.42% |
| 2 | Healthcare | 21.01% |
| 3 | Industrials | 15.6% |
| 4 | Consumer Discretionary | 7.82% |
| 5 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
101
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.84M | 0.24% |
243,462
-104,602
| -30% | -$3.37M |
|
102
Stoneridge
SRI
$234M
| $7.63M | 0.23% |
407,824
-76,661
| -16% | -$1.43M |
|
|
EGIO
103
DELISTED
Edgio, Inc. Common Stock
EGIO
| $7.53M | 0.23% |
238,068
-18,687
| -7% | -$591K |
|
104
Appian
APPN
$2.22B
| $7.5M | 0.23% |
168,929
+66,480
| +65% | +$2.95M |
|
105
SolarEdge
SEDG
$2.03B
| $7.47M | 0.23% |
24,585
+9,142
| +59% | +$2.78M |
|
106
CorVel
CRVL
$4.41B
| $7.12M | 0.22% |
112,215
-15,195
| -12% | -$964K |
|
107
Ambarella
AMBA
$3.44B
| $6.93M | 0.21% |
89,532
-115,081
| -56% | -$8.91M |
|
108
Kinsale Capital Group
KNSL
$10.7B
| $6.76M | 0.21% |
22,523
-1,122
| -5% | -$337K |
|
109
Mesa Laboratories
MLAB
$354M
| $6.62M | 0.2% |
37,911
+4,017
| +12% | +$702K |
|
110
Silicon Laboratories
SLAB
$4.43B
| $6.52M | 0.2% |
37,221
-4,149
| -10% | -$726K |
|
|
SWAV
111
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.39M | 0.19% |
29,481
+4,488
| +18% | +$973K |
|
112
AXT Inc
AXTI
$137M
| $6.22M | 0.19% |
1,562,282
+128,838
| +9% | +$513K |
|
113
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $6.19M | 0.19% |
574,940
+70,747
| +14% | +$761K |
|
114
Harvard Bioscience
HBIO
$20.8M
| $6.01M | 0.18% |
1,430,151
-32,306
| -2% | -$136K |
|
115
EPAM Systems
EPAM
$9.36B
| $5.91M | 0.18% |
19,777
-1,160
| -6% | -$347K |
|
116
Zymeworks
ZYME
$1.07B
| $5.88M | 0.18% |
650,389
-88,059
| -12% | -$796K |
|
117
Monolithic Power Systems
MPWR
$40.6B
| $5.81M | 0.18% |
11,603
+88
| +0.8% | +$44K |
|
118
TechTarget
TTGT
$404M
| $5.65M | 0.17% |
156,351
+1,478
| +1% | +$53.4K |
|
119
Grocery Outlet
GO
$1.78B
| $5.61M | 0.17% |
198,502
+8,185
| +4% | +$231K |
|
|
HSKA
120
DELISTED
Heska Corp
HSKA
| $5.56M | 0.17% |
56,949
-23,560
| -29% | -$2.3M |
|
121
Neogen
NEOG
$1.25B
| $5.51M | 0.17% |
+297,778
| New | +$5.51M |
|
122
Canadian Solar
CSIQ
$650M
| $5.42M | 0.16% |
+136,169
| New | +$5.42M |
|
123
Transmedics
TMDX
$3.55B
| $5.3M | 0.16% |
+69,959
| New | +$5.3M |
|
124
Cytosorbents Corp
CTSO
$61.2M
| $5.28M | 0.16% |
1,567,540
-26,171
| -2% | -$88.2K |
|
125
Stoke Therapeutics
STOK
$1.08B
| $5.03M | 0.15% |
603,524
+53,305
| +10% | +$444K |
|